NCT06818669 Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives
| NCT ID | NCT06818669 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York at Buffalo |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2030-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-06-01 with a primary completion date of 2030-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching aim of this proposal is to test the efficacy and cost-effectiveness of CVD-FIT, a novel, multi-component intervention that includes three components: 1) monthly income supplementation; 2) weekly structured incentive for the purchase of healthy food options; and 3) evidence-based telephone delivered CVD risk reduction education and skills training in African Americans with food insecurity.
Eligibility Criteria
Inclusion Criteria: * self-report as African American/non-Hispanic Black * screen positive for food insecurity over the past 12-months using a food insecurity risk tool developed through completion of the research team's current NIH funded R01 (R01MD013826) * at risk for CVD defined as age ≥40 years and having a clinical diagnosis of diabetes, or hypertension, or hyperlipidemia, or being overweight/obese (defined as a BMI\>25), or being a current smoker * able to communicate in English. Exclusion Criteria: * Mental confusion on interview suggesting significant dementia * Participation in other cardiovascular disease clinical trials * Alcohol or drug abuse/dependency based on screening using CAGE questionnaire * Active psychosis or acute mental disorder based on self-report * Life expectancy \<12 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06818669 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06818669 currently recruiting?
Yes, NCT06818669 is actively recruiting participants. Contact the research team at rbwalker@buffalo.edu for enrollment information.
Where is the NCT06818669 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT06818669 clinical trial?
NCT06818669 is sponsored by State University of New York at Buffalo. The trial plans to enroll 200 participants.